Skip to main content

Table 2 Selected in-hospital management, medications, and interventions according to discharge diagnosis

From: Management of acute coronary syndromes in a developing country; time for a paradigm shift? an observational study

  STEMI (n = 84) ACS (n = 172) Whole population (n = 256) P value
Aspirin (78) 92.9 % (166) 96.5 % (244) 95.3 % 0.194
Clopidogel (82) 97.6 % (169) 98.3 % (251) 98.0 % 0.464
Statins (81) 96.4 % (165) 95.9 % (246) 96.1 % 0.987
Beta blockers Atenolol (6) 7.1 % (23) 13.4 % (29) 11.3 % 0.073
Carvedilol (10) 11.9 % (11) 6.4 % (21) 8.2 %
Metaprolol (47) 56.0 % (79) 45.9 % (126) 49.2 %
Total (63) 75 % (113) 65.7 % (176) 68.7 %
ACEI, ARB Captopril (2) 2.4 % (21) 12.2 % (23) 9.0 % 0.946
Enalapril (66) 78.6 % (101) 58.7 % (167) 65.2 %
Losartan (5) 6 % (28) 16.3 % (33) 12.9 %
Total (73) 87 % (150) 87.2 % (223) 87.1 %
Nitrates (31) 36.9 % (72) 41.9 % (103) 40.9 % 0.145
Heparin (20) 23.8 % (28) 16.3 % (48) 18.8 % 0.167
Enoxaparin (52) 61.9 % (151) 87.8 % (203) 79.3 % 0.001
Diuretics (18) 21.4 % (25) 14.6 % (43) 16.9 % 0.209
Troponin done 19 (22.6 %) 70 (41.7 %) 89 (35.3 %) 0.004
Troponin positive in 19 (100 %) 42 (60 %) 61 (23.8 %) -
Fibrinolysis (59) 72.8 % (0) 0 % - -
Door to needle time: median (IQR) min 64 (55)    
<30 min (10) 16.9 %    
30–60 min (18) 30.5 %    
>60 min (31) 52.5 %    
Transferred to Ward 36 (43.3 %) 129 (78.2 %) 165 (67.6 %) 0.001
HDU 43 (58.1 %) 31 (19.3 %) 74 (30.3 %) 0.001
ICU 4 (4.8 %) 1 (0.6 %) 5 (2 %) 0.028
MACE 10 (11.9 %) 20 (11.6 %) 30 (11.7 %) 0.948
Echocardiography performed in 71 (84.5 %) 164 (95.3 %) 235 (91.8 %) 0.003
EF mean (%) 43.38 (SD 18.7) 52.65 (SD 13.6) 49.65 (SD 16.0) 0.001
Stress Test planned on discharge 19 (24.1 %) 44 (26.5 %) 63 (25.7 %) 0.866
Referred for PCI 1 (1.2 %) 0 (0 %) 1 (0.39 %)  
  Angiogram 9 (11.5 %) 11 (6.9 %) 20 (8.4 %)  
  CABG 0 (0 %) 1 (0.6 %) 1 (0.4 %)  
Mean duration of hospital stay 5.12 (SD = 1.430) 4.33 (SD = 2.089) 4.57 (SD = 1.946) 0.001